A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
Public ClinicalTrials.gov record NCT00196352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Multiple Site Study to Evaluate the Safety of an Extended Cycle Combination Oral Contraceptive, Seasonique, Which Utilizes Ethinyl Estradiol During the Pill-free Interval.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being conducted to evaluate the safety of ethinyl an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three consecutive years.
Study identification
- NCT ID
- NCT00196352
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 320 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 40 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2003
- Primary completion
- Oct 31, 2006
- Completion
- Oct 31, 2006
- Last update posted
- Apr 7, 2014
2003 – 2006
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duramed Investigational Site | Tucson | Arizona | 85715 | — |
| Duramed Investigational Site | Washington D.C. | District of Columbia | 20006 | — |
| Duramed Investigational Site | Lincoln | Nebraska | 68510 | — |
| Duramed Investigational Site | Rochester | New York | 14609 | — |
| Duramed Investigational Site | Charlotte | North Carolina | 28209 | — |
| Duramed Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Duramed Investigational Site | Columbus | Ohio | 43213 | — |
| Duramed Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Duramed Investigational Site | Nashville | Tennessee | 37203 | — |
| Duramed Investigational Site | Arlington | Virginia | 22203 | — |
| Duramed Investigational Site | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00196352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 7, 2014 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00196352 live on ClinicalTrials.gov.